User profiles for Chirag R. Parikh

Chirag Parikh

Johns Hopkins University
Verified email at jhmi.edu
Cited by 50268

[HTML][HTML] Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis

SG Coca, S Singanamala, CR Parikh - Kidney international, 2012 - Elsevier
Acute kidney injury may increase the risk for chronic kidney disease and end-stage renal
disease. In an attempt to summarize the literature and provide more compelling evidence, we …

Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis

…, B Yusuf, MG Shlipak, AX Garg, CR Parikh - American journal of …, 2009 - Elsevier
BACKGROUND: Acute kidney injury (AKI) is common in hospitalized patients. The impact of
AKI on long-term outcomes is controversial. STUDY DESIGN: Systematic review and meta-…

Factors associated with death in critically ill patients with coronavirus disease 2019 in the US

…, A Vijayan, JCQ Velez, S Shaefi, CR Parikh… - JAMA internal …, 2020 - jamanetwork.com
Importance The US is currently an epicenter of the coronavirus disease 2019 (COVID-19)
pandemic, yet few national data are available on patient characteristics, treatment, and …

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

…, R Mehta, O Moe, G Obrador, N Pannu, CR Parikh… - The Lancet, 2017 - thelancet.com
The global nephrology community recognises the need for a cohesive plan to address the
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …

Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis

…, RN Formica Jr, ED Poggio, CR Parikh - Nephrology dialysis …, 2009 - academic.oup.com
Background. Delayed graft function (DGF) is a common complication of renal transplantation.
The short-term consequences of DGF are well known, but the long-term relationship …

Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19

…, J Zhang, JCQ Velez, S Shaefi, CR Parikh… - JAMA internal …, 2021 - jamanetwork.com
Importance Therapies that improve survival in critically ill patients with coronavirus disease
2019 (COVID-19) are needed. Tocilizumab, a monoclonal antibody against the interleukin 6 …

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury

…, KD Liu, PD Brophy, LS Chawla, CR Parikh… - American Journal of …, 2013 - Elsevier
In response to the recently released 2012 KDIGO (Kidney Disease: Improving Global Outcomes)
clinical practice guideline for acute kidney injury (AKI), the National Kidney Foundation …

Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit

CR Parikh, E Abraham, M Ancukiewicz… - Journal of the …, 2005 - journals.lww.com
Serum creatinine is not an ideal marker of renal function in patients with acute kidney injury (AKI).
Previous studies demonstrated that urinary IL-18 is increased in human AKI. Thus, …

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

X Zhu, S Wu, WL Dahut, CR Parikh - American Journal of Kidney Diseases, 2007 - Elsevier
BACKGROUND: Angiogenesis inhibitors have emerged as an effective targeted therapy in
the treatment of patients with many cancers. One of the most widely used angiogenesis …

[PDF][PDF] Acute kidney injury in cirrhosis

G Garcia‐Tsao, CR Parikh, A Viola - Hepatology, 2008 - Wiley Online Library
Acute renal failure (ARF), recently renamed acute kidney injury (AKI), is a relatively frequent
problem, occurring in approximately 20% of hospitalized patients with cirrhosis. Although …